(9) De Alberti D, Bosoni D, Spissu F et al. Primary malignant melanoma of the endocervix uteri and outpatient hysteroscopy as a diagnostic tool: case report and literature overview. Diseases 2024; 12: 126. Doi: 10.3390/diseases12060126
(8) Scrimin F, Magoga G, Di Lorenzo G, Romano F, De Angelis MC, Vitagliano A, Carugno J, Di Spiezio Sardo A. Hysteroscopic treatment of primary endometrial marginal zone B-cell lymphoma (MALToma). Fact View Vis Obgyn 2019; 11: 257-260
(7) Garuti G, Sagrada PF, Mirra M, Marrazzo E, Migliaccio S et al. Breast cancer metastasis to endometrium: case report and up-date of literature. J Gynecol Res Obstet 2023; 9: 20-28. Doi: 10.17352/jgro.000121
(6) Raffone A, Travaglino A, Saccone G, Alviggi C, Mascolo M, De Placido G, Insabato L, Mollo A. Management of women with atypical polypoid adenomyoma of the uterus: a quantitative systematic review. Acta Obstet Gynecol Scand 2019; 98: 842-855. Doi: 10.1111/aogs.13553
(5) Nicolae A, Preda O, Nogales FF. Endometrial metaplasias and reactive changes: a spectrum of altered differentiation. J Clin Pathol 2011; 64: 97-106. Doi: 10.1136/jcp.2010.0855555
(4) Calzolari S, Comito C, Andersson KL, Giarrè G, Taddei GL, Dubini V. A case of exaggerated placental site treated with hysteroscopy. About Open Gynecology 2024; 11: 1-3. Doi: 10.33393/ao.2024.2611
(3) De Codt M, Jadoul P, Luyckx M et al. Hysteroscopic management of molar pregnancy: a series of 36 cases. Rare Tumors 2023; 15: 1-5. Doi: 1177/20363613231168767
(2) Gabrielli O, Orlandi G, Toscano P et al. Endometrial osseous metaplasia: a retrospective analysis and systematic review. J Clin Ultrasound 2025; 53: 2108-2116. Doi: 10.1002/jcu.24085
(1) Garuti G, Di Spiezio Sardo A, Mirra M, Calabrese S, Gonfiantini C, Di Mario M. Uterine arteriovenous malformation inadvertently treated by hysteroscopic resection. J Case Rep Images Gynecol Obstet 2015; 1: 20-24. Doi: 10.5348/Zo8-2015-6-CR-6
(3) Ianieri MM, Staniscia T, Pontrelli G et al. A new hysteroscopic risk scoring system for diagnosing endometrial hyperplasia and adenocarcinoma. JMIG 2016; 23: 712-718. Doi: 10.1016/j.jmig.2016.02.017
(7) Garuti G, De Giorgi O, Sambruni I, Cellani F, Luerti M. Prognostic significance of hysteroscopic imaging in endometrioid endometrial adenocarcinoma. Gynecol Oncol 2001; 81: 408-413. Doi: 10.1006/gyno.2001.6173
(6) Miyamoto T, Abiko K, Murakahi R et al. Hysteroscopic morphological pattern reflects histological grade of endometrial cancer. J Obstet Gynecol Res 2019; 45: 1479-1487. Doi: 10.111/jog.13998
(5) Garuti G, Sagrada PF, Frigoli A, Fornaciari O, Finco A, Mirra M, Soligo M. Hysteroscopic biopsy compared with endometrial curettage to assess the preoperative rate of atypical hyperplasia underestimating endometrial carcinoma. Arch Gynecol Obstet 2023; 308: 971-979. Doi: 10.1007/s00404-023-07060-2
(4) Di Spiezio Sardo A, De Angelis MC, Della Corte L et al. Should endometrial biopsy under direct hysterosopic visualization using the grasp technique become the new gold standard for the preoperative evaluation of the patient with endometrial cancer? Gynecol Oncol 2020; 158: 347-353. Doi: 10.1016/j.ygyno.2020.05.012
(2) Dueholm M, Hjorth IMD, Secher P, Jorgensen A, Ortoft G. Structured hysteroscopic evaluation of endometrium in women with postmenopausal bleeding. JMIG 2015; 22: 1215-1224. Doi: 10.1016/j.jmig.2015.06.018
(1) Berek JS, Matias-Guiu X, Creutzberg C et al. FIGO staging of endometrial cancer: 2023. Int J Gynecol Obstet 2023; 162: 383-394. Doi: 10.1002/ijgo.14923
(4) Garuti G, Castellacci E, Calabrese S, Calzolari S. Hysteroscopic removal of retained products of conception with enhanced vascularity: a study of reliability. CEOG 2020; 47: 472-477. Doi: 10.31083/j.ceog.2020.04.5259
(3) Pacheco LA, Timmons D, Naglub MS, Carugno J. Hysteroscopic management of retained products of conception: a single center observational study, FVVO 2019; 11: 217-222
(2) Tinelli AP, Haimovich S. Hysteroscopy. New York, NY, Springer Berlin Heidelberg, 2017
(1) Sellmyer MA, Desser TS, Maturen KE, Yeffrey RB, Kamaya A. Physiologic, histologic and imaging features of retained products of conception. Radiographics 2013; 33: 781-795. Doi: 10.1148/rg.333125177
(4) Garuti G, Sagrada PF, Mirra M, Fornaciari O, Centinaio G, Finco A, Soligo M. Hysteroscopic view of endometrial atypical hyperplasia. A helpful diagnostic tool in the care and treatment process? Eur J Gynecol Oncol 2024; 45: 8-15. Doi: 10.22514/ejgo.2024.022
(3) Garuti G, Mirra M, Luerti M. Hysteroscopic view in atypical endometrial hyperplasias: a correlation with pathologic findings on hysterectomy specimens. JMIG 2006; 13: 325-330. Doi: 10.1016/j.jmig.2006.03.010
(2) Garuti G, Cellani F, Garzia D, Colonnelli M, Luerti M. Accuracy of hysteroscopic diagnosis of endometrial hyperplasia: a retrospective study of 323 patients. JMIG 2005; 12: 247-253. Doi: 10.1016/j.jmig.2005.03.006
(1) Emons G, Beckmann MW, Schmidt D, Mallmann P. For the uterus commission of the Gynecological Oncology Working Group (AGO). New WHO classification of endometrial hyperplasias. Geburtsh Frauenheilk 2015; 75: 135-136. Doi: 10.1055/s-0034-1396256
(4) Di Spiezio Sardo A, Florio P, Nazzaro G, Spinelli M, Paladini D, Di Carlo C, Nappi C. Hysteroscopic outpatient metroplasty to expand dysmorphic uteri (HOME-DU technique): a pilot study. Reprod BioMedicine Online 2015; 30: 166-174. Doi: 10.1016/j.rbmo.2014.10.016
(3) Marchand GJ, Masoud A, Grover S, King A, Brazil G, Ulibarri H et al. First and second-generation endometrial ablation devices: a network meta-analysis. BMJ Open 2024; 14: e065966. Doi: 10.1136/bmjopen.2022-065966
(2) Casadio P, Guasina F, Talamo MR, Paradisi R, Morra C, Magnarelli G, Seracchioli R. Conservative hysteroscopic treatment of stage I well differentiated endometrial cancer in patients with high surgical risk: a pilot study. J Gynecol Oncol 2019; 30 (4): e62. Doi: 10.3802/jgo.2019.30e62
(1) Munro MG, Critchley HOD, Broder MS, Fraser IS, for the FIGO working group of menstrual disorders. FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age. Int J Gynecol Obstet 2011; 113: 3-13. Doi: 10.1016/j.ijgo.2010.11.011
(2) Gubbini G, Di Spiezio Sardo A, Nascetti D et al. New outpatient subclassification system for American Fertility Society classes V and VI uterine anomalies. J Minim Inv Gynecol 2009; 16: 554-561. Doi: 10.1016/j.jmig.2009.06.002
(1) Grimbizis GF, Gordts S, Di Spiezio Sardo A et al. The ESHRE/ESGE consensus on the classification of female genital tract congenital anomalies. Human Reproduction 2013; 28: 2032-2044. Doi: 10.1093/humrep/det098
(1) Shveiky D, Rojansky N, Revel A, Benshushan A, Laufer N, Shushan A. Complications of hysteroscopic surgery: “beyond the learning curve”. JMIG 2007; 14: 218-222. Doi: 10.1016/j.jmig.2006.07.019
(1) Philipp T, Philipp K, Reiner A, Beer F, Kalousek DK. Embryoscopic and cytogenetic analysis of 233 missed abortions: factors involved in the pathogenesis of developmental defects of early failed pregnancies. Hum Rep 2003; 18: 1724-1732. Doi: 10.1093/humrep/deg309
(1) Prat J, Mbatani N. Uterine sarcomas. Int J Gynecol Obstet 2015; 131: 105-110. Doi: 10.1016/j.ijgo.2015.06.006
(1) Lasmar RB, Lasmar BP, Haimovich S, Pacheco LA, Moawad NS. Proposal for a new classification of intrauterine adhesions by sites. Int J Gynecol Obstet 2024. Doi: 10.1002/ijgo.16034
(2) Resta L, Palumbo M, Rossi R, Piscitelli D, Fiore MG, Cicinelli E. Histology of micropolyps in chronic endometritis. Histopathology 2012; 60: 653-674. Doi: 10.1111/j.1365 2559.2011.04099x
(1) Tsonis O, Gkrozou F, Dimitriou E et al. Hysteroscopic features suggestive of chronic endometritis: a systematic review. Human Fertility 2023; 26: 1530-1543. Doi: 10.1080/14647273.2023.2265155
(1) Di Spiezio Sardo A, Calagna G, Santangelo F, Zizolfi B, Tanos V, Perino A, DeWilde RL. The role of hysteroscopy in the diagnosis and treatment of adenomyosis. Biomed Research International 2017. Doi: 10.1155/2017/2518396
(1) Munro MG, Critchley HOD, Broder MS, Fraser IS for the FIGO Working Group on menstrual disorders. FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age. Int J Gynecol Obstet 2011; 113: 3-13. Doi: 10.1016/j.ijgo.2010.11.011
(2) Rahimi S, Marani C, Renzi C, Natale ME, Giovannini P, Zeloni R. Endometrial polyp and the risk of atypical hyperplasia on biopsy of unremarkable endometrium: a study on 694 patients with benign endometrial polyps. Int J Gynecol Pathol 2009; 28: 522-528. Doi:10.1097/PGP.0b013e3181a42228
(1) Luerti M, Vitagliano A, Di Spiezio Sardo A et al. Effectiveness of hysteroscopic techniques for endometrial polyp removal: the Italian multicenter trial. JMIG 2019; 26: 1169-1176. Doi: 10.1016/j.jmig.2018.12.002
(4) Garuti G, Sagrada PF, Mirra M, Migliaccio S, Finco A, Soligo M. Hysteroscopic imaging of health endometrium in premenopausal breast cancer patients taking antiestrogenic therapies. Obstet Gynecol Res 2023; 6: 196-202. Doi: 10.26502/ogr0131
(3) Yamazaki R, Inokuchi M, Ishikawa S et al. Ovarian hyperstimulation closely associated with resumption of follicular growth after chemotherapy during tamoxifen treatment in premenopausal women with breast cancer: a multicenter retrospective cohort study. MBC Cancer 2020; 20: 67. Doi: 10.1186/s12885-02-6549-5
(2) International Agency for Research on Cancer (IARC), editor. Tamoxifen IARC monographs on the evaluation of carcinogenic risks to humans, vol. 66. Lyon (France): IARC; 1996. pp 253–365
(1) Burstein HJ, Lacchetti C, Anderson H et al. Adjuvant endocrine therapy for women with hormone-receptor-positive breast cancer. ASCO clinical practice guideline focused update. J Clin Oncol 2019; 37: 423-438. Doi: 10.1200/JCO.18.01160
(3) Bettocchi S, Bornowski WE, Doniec J, Ceci O, Resta L, Fascilla FD, Mitola PC, Tinelli F, Cicinelli E. Hysteroscopic patterns in women on treatment with Ulipristal acetate 5mg/day: a preliminary study. JMIG 2016; 5: 664-669. Doi: 10.1016/j.jmig.2016.01.010
(2) Kloosterboer HJ. Tissue selectivity: the mechanism of action of Tibolone. Maturitas 2004; 48: 30-40. Doi: 10.1016/j.maturitas.2004.02.012
(1) Garuti G, Colonnelli M, Soliani A, Lubrano C, Soligo M. Estroprogestin and progestogen intake: what’s the impact on hysteroscopic imaging? Fact Views Vis Obgyn 2023; 15: 61-67. Doi: 10.52054/FVVO.15.1.056
(2) Garuti G, Sagrada PF, Sogaro L, Migliaccio S, Farella M, Soligo M. Cesarean scar pregnancy treated by systemic or local methotrexate administration followed by hysteroscopic removal. A comparative pilot study. Clin Exp Obstet Gynecol 2023; 50: 67-74. Doi: 10.31083/j.ceog 5003067
(1) Gubbini G, Casadio P, Marra E. Resectoscopic correction of the “isthmocele” in women with postmenstrual uterine bleeding and secondary infertility. J Minim Invasive Gynecol 2008; 15: 172-175. Doi: 10.1016/j.jmig.2007.10.004
(2) Matteo M, Nappi L, Rosemberg P, Greco P. Combined medical-hysteroscopic conservative treatment of a viable cervical pregnancy: a case report. J Minim Invasive Gynecol 2006; 13: 345-347. Doi: 10.1016/j.jmig.2006.03.009
(1) Zizolfi B, Foreste V, Cammarota A, Manzi A, Gallo A, Di Spiezio Sardo A. Hysteroscopic approach to uterine cervical canal stenosis. Minerva Obstet Gynecol 2021; 73: 185-192. Doi: 10.23736/S2724-606X.20.04729-2
(1) Garuti G, Colonnelli M, Soliani A, Lubrano C, Soligo M. Estroprogestin and progestogen intake: what’s the impact on hysteroscopic imaging? Fact Views Vis Obgyn 2023; 15: 61-67. Doi: 10.52054/FVVO.15.1.056
(2) Kloosterboer HJ. Tissue selectivity: the mechanism of action of Tibolone. Maturitas 2004; 48: 30-40. Doi: 10.1016/j.maturitas.2004.02.012
(3) Bettocchi S, Bornowski WE, Doniec J, Ceci O, Resta L, Fascilla FD, Mitola PC, Tinelli F, Cicinelli E. Hysteroscopic patterns in women on treatment with Ulipristal acetate 5mg/day: a preliminary study. JMIG 2016; 5: 664-669. Doi: 10.1016/j.jmig.2016.01.010
